About MeVac, Meilahti Vaccine Research Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at MeVac, Meilahti Vaccine Research Center
During the past decade, MeVac, Meilahti Vaccine Research Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
2010-11-30
2020-09-10
Completed
799
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
2014-03-27
2021-04-16
Completed
389
24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease
2016-03-01
2019-06-01
Completed
208
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
2017-03-29
2019-06-11
Terminated
806
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-08-22
2022-11-28
Terminated
982
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)
2021-02-01
2023-03-06
Terminated
1,379
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "MeVac, Meilahti Vaccine Research Center"
#1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at MeVac, Meilahti Vaccine Research Center
According to Clinical.Site data, the most researched conditions in "MeVac, Meilahti Vaccine Research Center" are
"Pneumococcal Disease" (1 trials) and "SARS-CoV-2 Infection, COVID-19" (1 trials). Many other conditions were trialed in "MeVac, Meilahti Vaccine Research Center" in a lesser frequency.
Clinical Trials Intervention Types at MeVac, Meilahti Vaccine Research Center
Most popular intervention types in "MeVac, Meilahti Vaccine Research Center" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "BNT162b2 20mcg" (1 trials), "BNT162b2 30mcg" (1 trials) and "Biological/Vaccine: BNT162b2 10mcg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MeVac, Meilahti Vaccine Research Center
The vast majority of trials in "MeVac, Meilahti Vaccine Research Center" are
2 trials for "All" genders.
Clinical Trials Status at MeVac, Meilahti Vaccine Research Center
Currently, there are NaN active trials in "MeVac, Meilahti Vaccine Research Center".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in MeVac, Meilahti Vaccine Research Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MeVac, Meilahti Vaccine Research Center, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".